Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Raw Materials (2023 - 2025)

WORK Medical Technology filings provide 3 years of Raw Materials readings, the most recent being $527252.0 for Q3 2025.

  • On a quarterly basis, Raw Materials fell 12.87% to $527252.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $527252.0, a 12.87% decrease, with the full-year FY2025 number at $527252.0, down 12.87% from a year prior.
  • Raw Materials hit $527252.0 in Q3 2025 for WORK Medical Technology, down from $605154.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $741988.0 in Q3 2023 to a low of $527252.0 in Q3 2025.
  • Median Raw Materials over the past 3 years was $605154.0 (2024), compared with a mean of $624798.0.
  • Biggest five-year swings in Raw Materials: decreased 18.44% in 2024 and later dropped 12.87% in 2025.
  • WORK Medical Technology's Raw Materials stood at $741988.0 in 2023, then dropped by 18.44% to $605154.0 in 2024, then dropped by 12.87% to $527252.0 in 2025.
  • The last three reported values for Raw Materials were $527252.0 (Q3 2025), $605154.0 (Q3 2024), and $741988.0 (Q3 2023) per Business Quant data.